Global Companion Animal Specialty Drugs Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Companion Animal Specialty Drugs Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Companion Animal Specialty Drug is a kind of veterinary drugs that pet owners used to treatment and care of animals.
Companion Animal Specialty Drugs report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Companion Animal Specialty Drugs market is projected to reach US$ 17200 million in 2034, increasing from US$ 12530 million in 2022, with the CAGR of 4.6% during the period of 2024 to 2034. Demand from Veterinary Hospitals and Pet Care Clinics are the major drivers for the industry.
The Americas has the presence of large veterinary markets such as the US and Canada. The companion animal specialty drugs market is witnessing continuous growth in the region due to the rising awareness and the availability of companion animal healthcare. Furthermore, the increase in disposable incomes of pet owners and economic development, will also contribute to the growth of the market in this region.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Companion Animal Specialty Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Bayer
Elanco
Merial
Zoetis
Aratana therapeutics
Beaphar
Henry Schein
Mars
The J.M Smucker Company
Segment by Type
Vaccines
Antibiotics
Parasiticides
Feed Additives
Other
Veterinary Hospitals
Pet Care Clinics
Pharmacy Stores
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Companion Animal Specialty Drugs market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Companion Animal Specialty Drugs, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Companion Animal Specialty Drugs industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Companion Animal Specialty Drugs in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Companion Animal Specialty Drugs introduction, etc. Companion Animal Specialty Drugs Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Companion Animal Specialty Drugs market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Companion Animal Specialty Drugs report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Companion Animal Specialty Drugs market is projected to reach US$ 17200 million in 2034, increasing from US$ 12530 million in 2022, with the CAGR of 4.6% during the period of 2024 to 2034. Demand from Veterinary Hospitals and Pet Care Clinics are the major drivers for the industry.
The Americas has the presence of large veterinary markets such as the US and Canada. The companion animal specialty drugs market is witnessing continuous growth in the region due to the rising awareness and the availability of companion animal healthcare. Furthermore, the increase in disposable incomes of pet owners and economic development, will also contribute to the growth of the market in this region.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Companion Animal Specialty Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Bayer
Elanco
Merial
Zoetis
Aratana therapeutics
Beaphar
Henry Schein
Mars
The J.M Smucker Company
Segment by Type
Vaccines
Antibiotics
Parasiticides
Feed Additives
Other
Segment by Application
Veterinary Hospitals
Pet Care Clinics
Pharmacy Stores
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Companion Animal Specialty Drugs market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Companion Animal Specialty Drugs, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Companion Animal Specialty Drugs industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Companion Animal Specialty Drugs in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Companion Animal Specialty Drugs introduction, etc. Companion Animal Specialty Drugs Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Companion Animal Specialty Drugs market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices